Grifols SA, Barcelona

Pharmaceuticals
Spain
Earnings Per Share Growth (%)13.87%
Cost of Goods Sold (US$ Millions)$2,182
Current Liabilities (US$ Millions)$1,147
Total Assets (US$ Millions)$3,365
Long Term Debt$0
Return on Equity20.02%
Revenue (US$ Millions)$4,286
Total Company Assets$10,458
Revenue Growth (%)17.26%
Net Income (US$ Millions)$580
Earnings Per Share (US$)$13.87
Total Equity (US$ Millions)$3,590
Profit Margin (%)13.52%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$1,559